Publication:
Efficacy of experimental treatments compared with standard treatments in non-inferiority trials: a meta-analysis of randomized controlled trials

cris.virtual.author-orcid0000-0001-7462-5132
cris.virtualsource.author-orcida47a659b-5a23-43fa-86e3-f9401108114c
datacite.rightsopen.access
dc.contributor.authorSoonawala, Darius
dc.contributor.authorMiddelburg, Rutger A
dc.contributor.authorEgger, Matthias
dc.contributor.authorVandenbroucke, Jan P
dc.contributor.authorDekkers, Olaf M
dc.date.accessioned2024-10-10T20:40:16Z
dc.date.available2024-10-10T20:40:16Z
dc.date.issued2010
dc.description.abstractBackground There is concern that non-inferiority trials might be deliberately designed to conceal that a new treatment is less effective than a standard treatment. In order to test this hypothesis we performed a meta-analysis of non-inferiority trials to assess the average effect of experimental treatments compared with standard treatments. Methods One hundred and seventy non-inferiority treatment trials published in 121 core clinical journals were included. The trials were identified through a search of PubMed (1991 to 20 February 2009). Combined relative risk (RR) from meta-analysis comparing experimental with standard treatments was the main outcome measure. Results The 170 trials contributed a total of 175 independent comparisons of experimental with standard treatments. The combined RR for all 175 comparisons was 0.994 [95% confidence interval (CI) 0.978–1.010] using a random-effects model and 1.002 (95% CI 0.996–1.008) using a fixed-effects model. Of the 175 comparisons, experimental treatment was considered to be non-inferior in 130 (74%). The combined RR for these 130 comparisons was 0.995 (95% CI 0.983–1.006) and the point estimate favoured the experimental treatment in 58% (n = 76) and standard treatment in 42% (n = 54). The median non-inferiority margin (RR) pre-specified by trialists was 1.31 [inter-quartile range (IQR) 1.18–1.59]. Conclusion In this meta-analysis of non-inferiority trials the average RR comparing experimental with standard treatments was close to 1. The experimental treatments that gain a verdict of non-inferiority in published trials do not appear to be systematically less effective than the standard treatments. Importantly, publication bias and bias in the design and reporting of the studies cannot be ruled out and may have skewed the study results in favour of the experimental treatments. Further studies are required to examine the importance of such bias.
dc.description.numberOfPages15
dc.description.sponsorshipInstitut für Sozial- und Präventivmedizin (ISPM)
dc.identifier.doi10.7892/boris.1142
dc.identifier.isi000284952700025
dc.identifier.pmid20837637
dc.identifier.publisherDOI10.1093/ije/dyq136
dc.identifier.urihttps://boris-portal.unibe.ch/handle/20.500.12422/71883
dc.language.isoen
dc.publisherOxford University Press
dc.publisher.placeOxford
dc.relation.ispartofInternational journal of epidemiology
dc.relation.issn0300-5771
dc.relation.organizationInstitute of Social and Preventive Medicine
dc.titleEfficacy of experimental treatments compared with standard treatments in non-inferiority trials: a meta-analysis of randomized controlled trials
dc.typearticle
dspace.entity.typePublication
dspace.file.typetext
oaire.citation.endPage1581
oaire.citation.issue6
oaire.citation.startPage1567
oaire.citation.volume39
oairecerif.author.affiliationInstitut für Sozial- und Präventivmedizin (ISPM)
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.date.licenseChanged2019-10-30 18:53:54
unibe.description.ispublishedpub
unibe.eprints.legacyId1142
unibe.journal.abbrevTitleINT J EPIDEMIOL
unibe.refereedtrue
unibe.subtype.articlejournal

Files

Original bundle
Now showing 1 - 1 of 1
Name:
Soonawala IntJEpidemiol 2010.pdf
Size:
268.11 KB
Format:
Adobe Portable Document Format
File Type:
text
License:
publisher
Content:
published

Collections